Changchun BCHT Biotechnology Co
SSE:688276
Wall Street
Price Targets
Price Targets Summary
Changchun BCHT Biotechnology Co
According to Wall Street analysts, the average 1-year price target for Changchun BCHT Biotechnology Co is 63.43 CNY with a low forecast of 54.67 CNY and a high forecast of 84 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Changchun BCHT Biotechnology Co
For the last 3 years the compound annual growth rate for Changchun BCHT Biotechnology Co's operating income is -16%. The projected CAGR for the next 4 years is 65%.
Net Income
Forecast
Net Income Estimate
Changchun BCHT Biotechnology Co
For the last 3 years the compound annual growth rate for Changchun BCHT Biotechnology Co's net income is -6%. The projected CAGR for the next 4 years is 39%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Changchun BCHT Biotechnology Co's stock price target?
Price Target
63.43
CNY
According to Wall Street analysts, the average 1-year price target for Changchun BCHT Biotechnology Co is 63.43 CNY with a low forecast of 54.67 CNY and a high forecast of 84 CNY.
What is Changchun BCHT Biotechnology Co's Revenue forecast?
Projected CAGR
37%
For the last 3 years the compound annual growth rate for Changchun BCHT Biotechnology Co's revenue is 3%. The projected CAGR for the next 4 years is 37%.
What is Changchun BCHT Biotechnology Co's Operating Income forecast?
Projected CAGR
65%
For the last 3 years the compound annual growth rate for Changchun BCHT Biotechnology Co's operating income is -16%. The projected CAGR for the next 4 years is 65%.
What is Changchun BCHT Biotechnology Co's Net Income forecast?
Projected CAGR
39%
For the last 3 years the compound annual growth rate for Changchun BCHT Biotechnology Co's net income is -6%. The projected CAGR for the next 4 years is 39%.